These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 18354391)

  • 1. Genetic variations of human neuropsin gene and psychiatric disorders: polymorphism screening and possible association with bipolar disorder and cognitive functions.
    Izumi A; Iijima Y; Noguchi H; Numakawa T; Okada T; Hori H; Kato T; Tatsumi M; Kosuga A; Kamijima K; Asada T; Arima K; Saitoh O; Shiosaka S; Kunugi H
    Neuropsychopharmacology; 2008 Dec; 33(13):3237-45. PubMed ID: 18354391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No association of the MCP-1 promoter A-2518G polymorphism with bipolar disorder in the Korean population.
    Roh MS; Lee KY; Joo EJ; Lee N; Kim YS
    Neurosci Lett; 2007 Oct; 427(1):1-5. PubMed ID: 17928143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance.
    Burdick KE; Funke B; Goldberg JF; Bates JA; Jaeger J; Kucherlapati R; Malhotra AK
    Bipolar Disord; 2007 Jun; 9(4):370-6. PubMed ID: 17547583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
    Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MCP-1 gene (SCYA2) and mood disorders: preliminary results of a case-control association study.
    Altamura AC; Mundo E; Cattaneo E; Pozzoli S; Dell'osso B; Gennarelli M; Vergani C; Trabattoni D; Arosio B; Clerici M
    Neuroimmunomodulation; 2010; 17(2):126-31. PubMed ID: 19923858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the trace amine associated receptor 6 (TAAR6) gene with schizophrenia and bipolar disorder in a Korean case control sample.
    Pae CU; Yu HS; Amann D; Kim JJ; Lee CU; Lee SJ; Jun TY; Lee C; Paik IH; Patkar AA; Lerer B
    J Psychiatr Res; 2008 Jan; 42(1):35-40. PubMed ID: 17097106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do schizophrenia and bipolar disorders share a common disease susceptibility variant at the MMP3 gene?
    Kucukali CI; Aydin M; Ozkok E; Bilge E; Orhan N; Zengin A; Kara I
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):557-61. PubMed ID: 19245826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lymphotoxin Cys13Arg polymorphism and cognitive functioning in individuals with schizophrenia.
    Dickerson F; Boronow J; Stallings C; Origoni A; Yolken R
    Schizophr Res; 2007 Jan; 89(1-3):173-6. PubMed ID: 17029750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional polymorphism (C-824T) of the tyrosine hydroxylase gene affects IQ in schizophrenia.
    Horiguchi M; Ohi K; Hashimoto R; Hao Q; Yasuda Y; Yamamori H; Fujimoto M; Umeda-Yano S; Takeda M; Ichinose H
    Psychiatry Clin Neurosci; 2014 Jun; 68(6):456-62. PubMed ID: 24417771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between DAOA gene polymorphisms and the risk of schizophrenia, bipolar disorder and depressive disorder.
    Tan J; Lin Y; Su L; Yan Y; Chen Q; Jiang H; Wei Q; Gu L
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():89-98. PubMed ID: 24447945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COMT polymorphisms as predictors of cognitive dysfunction during manic and mixed episodes in bipolar I disorder.
    Soeiro-de-Souza MG; Machado-Vieira R; Soares Bio D; Do Prado CM; Moreno RA
    Bipolar Disord; 2012 Aug; 14(5):554-64. PubMed ID: 22713126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genetic variation in the dysbindin gene (DTNBP1) is associated with memory performance in healthy controls.
    Hashimoto R; Noguchi H; Hori H; Nakabayashi T; Suzuki T; Iwata N; Ozaki N; Kosuga A; Tatsumi M; Kamijima K; Harada S; Takeda M; Saitoh O; Kunugi H
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):431-8. PubMed ID: 19353385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-10 gene promoter polymorphism in patients with schizophrenia in a region of East Turkey.
    Ozbey U; Tug E; Namli M
    World J Biol Psychiatry; 2009; 10(4 Pt 2):461-8. PubMed ID: 19153889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in the promoter region of the alpha1A-adrenoceptor gene are associated with schizophrenia/schizoaffective disorder in a Spanish isolate population.
    Clark DA; Arranz MJ; Mata I; Lopéz-Ilundain J; Pérez-Nievas F; Kerwin RW
    Biol Psychiatry; 2005 Sep; 58(6):435-9. PubMed ID: 16043131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism in SNAP29 gene promoter region associated with schizophrenia.
    Saito T; Guan F; Papolos DF; Rajouria N; Fann CS; Lachman HM
    Mol Psychiatry; 2001 Mar; 6(2):193-201. PubMed ID: 11317222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: evidence for a common genetic vulnerability?
    Peerbooms OL; van Os J; Drukker M; Kenis G; Hoogveld L; ; de Hert M; Delespaul P; van Winkel R; Rutten BP
    Brain Behav Immun; 2011 Nov; 25(8):1530-43. PubMed ID: 21185933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies.
    Zintzaras E
    Psychiatr Genet; 2006 Jun; 16(3):105-15. PubMed ID: 16691128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between polymorphisms in the vesicle-associated membrane protein-associated protein A (VAPA) gene on chromosome 18p and bipolar disorder.
    Lohoff FW; Weller AE; Bloch PJ; Nall AH; Ferraro TN; Berrettini WH
    J Neural Transm (Vienna); 2008 Sep; 115(9):1339-45. PubMed ID: 18665321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder.
    Matsuo K; Walss-Bass C; Nery FG; Nicoletti MA; Hatch JP; Frey BN; Monkul ES; Zunta-Soares GB; Bowden CL; Escamilla MA; Soares JC
    Neuropsychopharmacology; 2009 Jul; 34(8):1904-13. PubMed ID: 19295510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genetic association study of the FXYD domain containing ion transport regulator 6 (FXYD6) gene, encoding phosphohippolin, in susceptibility to schizophrenia in a Japanese population.
    Ito Y; Nakamura Y; Takahashi N; Saito S; Aleksic B; Iwata N; Inada T; Ozaki N
    Neurosci Lett; 2008 Jun; 438(1):70-5. PubMed ID: 18455306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.